Abstract:BACKGROUND:The expression and function of the Receptor for Activated C Kinase 1 (RACK1) in cancer growth and metastasis are confused in different cancers, especially in pancreatic ductal adenocarcinoma (PDAC). METHODS:One-hundred and eighty-two PDAC tissue specimens (95 males and 87 females) including pancreatic cancer tissue and para-carcinoma tissue were collected for analysis between 2005 to 2012. Blood phenotypic parameters using cell count and capillary electrophoresis were investigated. HE staining, real time PCR, Western blot analysis, and soft agar assays were performed to determine the role of RACK1. PURPOSE:In this study, we aim to determine the specific role of RACK1 in the untility of PDAC. RESULTS:We found that RACK1 expression was significantly lower in pancreatic cancer tissue than in para-carcinoma normal pancreatic tissue both in clinic and mice with pancreatic cancer at the early stage. Our results suggested that RACK1 silence could significantly promote cell growth and metastasis of pancreatic cancer cells. But we found that the overexpression of RACK1 has the opposite effect in vitro. In vivo MIAPaca-2 cells overexpressing RACK1, the results demonstrated lower metastatic ability than MIAPaca-2 cells. RACK1 overexpression could decrease the NF-κB transactivation activity of MIAPaca-2 cells, which was consistent with the inhibitory effect of RACK1 overexpression on the pro-migration and pro-invasive target gene of NF-κB, while which could be increased by RACK1 silence. RACK1 silence also enhanced protein expression of pro-migration and pro-invasive NF-κB target genes, which on the contrary, could be reversed by IκBα. Besides, RACK1 expression was significantly associated with lymph node metastasis, vessels metastasis, invasion of nerves as well as TNM staging. The 3-year survival rate of patients with high RACK1 expression was significantly higher than those patients with low RACK1 expression. However, RACK1 expression was not an independent risk factor for of the long-term postoperative survival of patients with pancreatic cancer. CONCLUSION:The obtained results in our study suggested that the low expression of RACK1 was associated with cancer cell growth and metastasis in pancreatic cancer through the activation of the NF-κB pathway. RACK1 could be a potential therapeutic drug target to pancreatic cancer and metastasis.

Expression of RACK1 in carcinogenic process of colorectal adenocarcinoma and its significance

RACK1 promotes the occurrence and progression of cervical carcinoma

Downregulated expression of RACK1 results in pancreatic cancer growth and metastasis.

Low Expression of RACK1 is Associated with Metastasis and Worse Prognosis in Cholangiocarcinoma

RACK1 Promotes Breast Carcinoma Migration/metastasis Via Activation of the RhoA/Rho Kinase Pathway

RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo

RACK1: A Superior Independent Predictor for Poor Clinical Outcome in Breast Cancer

RACK1 promotes cancer progression by increasing the M2/M1 macrophage ratio via the NF‐κB pathway in oral squamous cell carcinoma

RACK1 to Modulate Expression of MMP10 Via Src/NF-κB Pathway in Gastric Cancer.

RACK1 Promotes Radiation Resistance in Esophageal Cancer Via Regulating AKT Pathway and Bcl-2 Expression.

RACK1 Promoted the Growth and Migration of the Cancer Cells in the Progression of Esophageal Squamous Cell Carcinoma

RACK1 Promotes Non-small-cell Lung Cancer Tumorigenicity through Activating Sonic Hedgehog Signaling Pathway

The research on expression and mechanism of Ca2+/calmodulin-dependent protein kinaseδin colorectal cancer

PAK1-dependent MAPK Pathway Activation is Required for Colorectal Cancer Cell Proliferation

Response to ‘evidence for a Pro-Apoptotic Function of RACK1 in Human Breast Cancer’

RACK1 promotes the invasive activities and lymph node metastasis of cervical cancer via galectin-1

RACK1 Induces Chemotherapy Resistance in Esophageal Carcinoma by Upregulating the PI3K/AKT Pathway and Bcl-2 Expression

Clinical Significance of eIF4E and CyclinD1 Expression in Primary Colorectal Cancer

Expression and clinical significance of RCC1 in rectal cancer tissues

RACK1 facilitates breast cancer progression by competitively inhibiting the binding of β-catenin to PSMD2 and enhancing the stability of β-catenin

RACK1 Suppresses Gastric Tumorigenesis by Stabilizing the Β-Catenin Destruction Complex